TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy

Launched by TAIPEI CITY HOSPITAL · Mar 23, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how a program called "Traditional Chinese Medicine Therapy for Reinforcing Vital Energy" can help breast cancer patients who are also receiving standard Western medical treatments. The study aims to find out if this program can reduce some of the uncomfortable symptoms that breast cancer patients experience, improve their overall quality of life, and help manage side effects from traditional cancer treatments like chemotherapy and radiation.

To participate, individuals must be between 18 and 85 years old and have a confirmed diagnosis of breast cancer. Participants will take part in the therapy program, which includes various supportive services such as lifestyle education, psychological counseling, and additional Chinese medicine treatments. This trial emphasizes the importance of treating not just the physical aspects of cancer but also considering mental and social well-being. If you or someone you know is interested in participating, it’s important to check eligibility and understand what the program involves.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study.
• • Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine.
• • Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy.
• Exclusion Criteria:
• • Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine.
• • Patients regularly receiving Astragalus polysaccharide injections.
• • Patients with a history of allergies to Traditional Chinese Medicine.
• • Pregnant or breastfeeding women.
• • Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs.
• • Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).